Back to MW MARSHALL WACE, LLP
NGEN2 quarters
Position history for MWMARSHALL WACE, LLP's holdings in NERVGEN PHARMA CORP
Yes. Marshall Wace holds 435,962 shares of NGEN (Nervgen Pharma), worth $898,081, as of its Q2 2026 13F filing. It increased the position by 235,603 shares (+117.6%) from Q1 2026. Marshall Wace has held NGEN in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$898,081
Current Shares
435,962
Total Value Change
+$142,726
Total Shares Change
+235,603
Quarter-by-Quarter History
Other major holders of NGEN: LMR Partners LLP, UBS Group AG, BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA, JANE STREET GROUP, LLC